How to guarantee access to and fair prices for COVID-19 medicine and vaccines with public investment
Home Slider
How to guarantee access to and fair prices for COVID-19 medicine and vaccines with public investment
23/04/2020 by in Home Slider
We appeal for measures to safeguard the public health system and ensure access to treatment and vaccines for COVID-19
Home Slider
We appeal for measures to safeguard the public health system and ensure access to treatment and vaccines for COVID-19
15/04/2020 by in Home Slider
Global pandemic, global solutions
Home Slider
Global pandemic, global solutions
07/04/2020 by in Home Slider
Gilead: ensure access to remdesivir, a promising treatment for coronavirus (Open letter)
Home Slider
Gilead: ensure access to remdesivir, a promising treatment for coronavirus (Open letter)
31/03/2020 by in Home Slider
Open letter to the World Health Organization (WHO) and its Member States
Home Slider
Open letter to the World Health Organization (WHO) and its Member States
27/03/2020 by in Home Slider
Pharmaceutical Policy in Times of Health Emergency
Home Slider
Pharmaceutical Policy in Times of Health Emergency
27/03/2020 by in Home Slider
Open letter to the EU: the treatments developed for COVID19 with public money must be accessible
Home Slider
Open letter to the EU: the treatments developed for COVID19 with public money must be accessible
26/03/2020 by in Home Slider
What are we learning from the coronavirus crisis?
Home Slider
What are we learning from the coronavirus crisis?
19/03/2020 by in Home Slider
‘Transparency has an impact on the population’s health’
Home Slider
‘Transparency has an impact on the population’s health’
17/02/2020 by in Home Slider
A great victory for transparency
Home Slider
A great victory for transparency
30/01/2020 by in Home Slider
We review 2019… and wish you happy 2020!
Home Slider
We review 2019… and wish you happy 2020!
30/12/2019 by in Home Slider
We won a Desalambre award!
Home Slider
We won a Desalambre award!
19/12/2019 by in Home Slider
“The opacity in the medicine market is antidemocratic”
Home Slider
“The opacity in the medicine market is antidemocratic”
11/12/2019 by in Home Slider
Novartis goes to court to try to prevent the government from making information public about the approval of one of its most innovative treatments
Home Slider
Novartis goes to court to try to prevent the government from making information public about the approval of one of its most innovative treatments
28/10/2019 by in Home Slider
This is our 2018 annual report
Home Slider
This is our 2018 annual report
15/10/2019 by in Home Slider
The role of Spain in a key week for global health
Home Slider
The role of Spain in a key week for global health
27/09/2019 by in Home Slider